Target intelligence / Profile preview

B3GNTL1 pseudogene 1 (B3GNTL1P1)

Target: B3GNTL1P1
Molecular classification: Other

Overview

B3GNTL1 pseudogene 1 (B3GNTL1P1) is a human genomic element classified as a pseudogene, specifically related to UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1. Pseudogenes are non-functional copies of genes, typically lacking the capacity to produce functional proteins due to mutations or gene disabling events. While its parent family (such as B3GNTL1 or B3GNT3) encodes glycosyltransferases involved in glycan biosynthesis and cell signaling, B3GNTL1P1 itself is not an enzyme and does not perform biological or pathogenic roles relevant to therapeutic targeting[2][4].

Other names: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 pseudogene 1B3GNTL1P1[2][4]

Beyond the preview

Go deeper on B3GNTL1 pseudogene 1 (B3GNTL1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on B3GNTL1 pseudogene 1 (B3GNTL1P1).

Explore the full profile